Turkish Journal of Nephrology
Report

Mind the Gap in Kidney Care: Translating What We Know into what we do

1.

Department of Public and Global Health, Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, Switzerland

2.

Renal Division, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts, USA

3.

Department of Paediatrics and Child Health, University of Cape Town, Cape Town, South Africa

4.

Providence Medical Research Center, Providence Inland Northwest Health, Spokane, Washington, USA

5.

Nephrology Division, Department of Medicine, University of Washington, Seattle, Washington, USA

6.

Department of Nephrology, Cairo University Hospital, Cairo, Egypt

7.

Department of Nephrology and Mineral Metabolism, National Medical Science and Nutrition Institute Salvador Zubiran, Mexico City, Mexico

8.

Department of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong, China

9.

Department of Nephrology, Péterfy Hospital, Budapest, Hungary

10.

ISN Patient Liaison Advisory Group

11.

Tamilnad Kidney Research (TANKER) Foundation, Chennai, India

12.

2nd Department of Nephrology, AHEPA University Hospital Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece

13.

Department of Medicine, College of Medicine, University of Nigeria, Ituku-Ozalla, Enugu, Nigeria

14.

Division of Health System, Policy and Management, Jockey Club School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong

15.

Italian Kidney Foundation, Rome, Italy

Turkish J Nephrol 2024; 33: 122-133
DOI: 10.5152/turkjnephrol.2024.242903
Read: 439 Downloads: 304 Published: 09 April 2024

Historically, it takes an average of 17 years to move new treatments from clinical evidence to daily practice. Given the highly efective treatments now available to prevent or delay kidney disease onset and progression, this is far too long. The time is now to narrow the gap between what we know and what we do. Clear guidelines exist for the prevention and management of common risk factors for kidney disease, such as hypertension and diabetes, but only a fraction of people with these conditions worldwide are diagnosed, and even fewer are treated to target. Similarly, the vast majority of people living with kidney disease are unaware of their condition, because in the early stages it is ofen silent. Even among patients who have been diagnosed, many do not receive appropriate treatment for kidney disease. Considering the serious consequences of kidney disease progression, kidney failure, or death, it is imperative that treatments are initiated early and appropriately. Opportunities to diagnose and treat kidney disease early must be maximized beginning at the primary care level. Many systematic barriers exist, ranging from patient to clinician to health systems to societal factors. To preserve and improve kidney health for everyone everywhere, each of these barriers must be acknowledged so that sustainable solutions are developed and implemented without further delay.

Cite this article as: Luyckx VA, Tuttle KR, Abdellatif D, et al. Mind the gap in kidney care: translating what we know into what we do. Turk J Nephrol. 2024; 33(2):122-133.

Files
EISSN 2667-4440